Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/58682
Title: Identifying clinically significant novel drug candidate for highly prevalent Alzheimer's disease
Authors: Ali L, Benazir
A, Subramani
T, Baskar
Shabeer, T K
Keywords: ADME;Lipinski rule;Bioavailability;Curcumin-schiff base;Molecular simulation;Alzheimer’s disease
Issue Date: Sep-2021
Publisher: NIScPR-CSIR, India
Abstract: Pharmacokinetics is very important in target validation and in shifting a lead compound into a drug. It is a cumbersome process in clinical research. A quantitative personation based on computed, pharmacokinetics, physicochemical properties, ILOGP, drug-likeness, medicinal chemistry friendliness, bioavailability radar and BOILED-Egg for all the synthesized, 6 novel compounds have been assessed using Swiss ADME. An effective drug can be produced from the physicochemical properties discussed in this model. The physicochemical properties of all designed Schiff bases of curcumin have been found to be optimal and so, they are perceived to have acceptable oral absorption and adequate permeability. All the monomers obeyed the rule of five by Lipinski and the oral bioavailability is accounted worldwide. The desired set of monomers have been enhanced by effective ADME screening and molecular simulation methods with Microtubuleassociated protein tau (MAPT) (PDB code: 10636) receptor could represent favourable building blocks as preferable chemotherapeutic factor in resistance to Alzheimers disease.
Page(s): 618-623
URI: http://nopr.niscair.res.in/handle/123456789/58682
ISSN: 0975-0991 (Online); 0971-457X (Print)
Appears in Collections:IJCT Vol.28(5) [September 2021]

Files in This Item:
File Description SizeFormat 
IJCT 28(5) 618-623.pdf1.58 MBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.